Novartis Case Tests India's IP Climate
Novartis AG's ongoing battle to patent its cancer treatment Gleevec in India has seen the drug maker challenge not only the rejection of its patent application earlier this year, but a...To view the full article, register now.
Already a subscriber? Click here to view full article